Sorrento

Sorrento buys Kimberly-Clark’s Sofusa lymphatic delivery platform

US-based biopharmaceutical company Sorrento Therapeutics has acquired the Sofusa lymphatic delivery technology platform from Kimberly-Clark Corporation. Sorrento intends to use…